메뉴 건너뛰기




Volumn 136, Issue 1, 2018, Pages 29-38

Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: A DRCR network phase 2 randomized clinical trial

(394)  Maturi, Raj K a   Glassman, Adam R b   Liu, Danni b   Beck, Roy W b   Bhavsar, Abdhish R c   Bressler, Neil M d   Jampol, Lee M e   Melia, Michele b   Punjabi, Omar S f   Salehi Had, Hani g   Sun, Jennifer K h   Browning, David f   Antoszyk, Andrew N f   Price, Angela K f   Herby, Jenna T f   Jones, Taylor S f   Fredenberg, Sherry L f   Mahr, Courtney f   Fleming, Christina J f   Ennis, Sarah A f   more..


Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; DEXAMETHASONE; HEMOGLOBIN A1C; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; VASCULOTROPIN A;

EID: 85041102566     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2017.4914     Document Type: Article
Times cited : (198)

References (17)
  • 1
    • 77952779304 scopus 로고    scopus 로고
    • Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
    • Elman MJ, Aiello LP, Beck RW, et al; Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077.e35.
    • (2010) Ophthalmology , vol.117 , Issue.6 , pp. 1064-1077
    • Elman, M.J.1    Aiello, L.P.2    Beck, R.W.3
  • 2
    • 84925423332 scopus 로고    scopus 로고
    • Diabetic Retinopathy Clinical Research Network. Aflibercept bevacizumab or ranibizumab for diabetic macular edema
    • Wells JA, Glassman AR, Ayala AR, et al; Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193-1203.
    • (2015) N Engl J Med , vol.372 , Issue.13 , pp. 1193-1203
    • Wells, J.A.1    Glassman, A.R.2    Ayala, A.R.3
  • 3
    • 84863401792 scopus 로고    scopus 로고
    • RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE
    • Nguyen QD, Brown DM, Marcus DM, et al; RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4): 789-801.
    • (2012) Ophthalmology , vol.119 , Issue.4 , pp. 789-801
    • Nguyen, Q.D.1    Brown, D.M.2    Marcus, D.M.3
  • 4
    • 79953311138 scopus 로고    scopus 로고
    • RESTORE Study Group.The restore study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema
    • Mitchell P, Bandello F, Schmidt-Erfurth U, et al; RESTORE Study Group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625.
    • (2011) Ophthalmology , vol.118 , Issue.4 , pp. 615-625
    • Mitchell, P.1    Bandello, F.2    Schmidt-Erfurth, U.3
  • 5
    • 0032509788 scopus 로고    scopus 로고
    • Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells
    • Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 1998;341(2-3):309-315.
    • (1998) Eur J Pharmacol , vol.341 , Issue.2-3 , pp. 309-315
    • Nauck, M.1    Karakiulakis, G.2    Perruchoud, A.P.3    Papakonstantinou, E.4    Roth, M.5
  • 6
    • 0023626528 scopus 로고
    • Angiostatic steroids: Method of discovery and mechanism of action
    • Folkman J, Ingber DE. Angiostatic steroids: method of discovery and mechanism of action. Ann Surg. 1987;206(3):374-383.
    • (1987) Ann Surg , vol.206 , Issue.3 , pp. 374-383
    • Folkman, J.1    Ingber, D.E.2
  • 8
    • 50249149459 scopus 로고    scopus 로고
    • Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
    • 1449.e1-e10
    • Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115(9):1447-1449, 1449.e1-e10.
    • (2008) Ophthalmology , vol.115 , Issue.9 , pp. 1447-1449
  • 9
    • 84908118639 scopus 로고    scopus 로고
    • Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
    • Boyer DS, Yoon YH, Belfort R Jr, et al; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904-1914.
    • (2014) Ophthalmology , vol.121 , Issue.10 , pp. 1904-1914
    • Boyer, D.S.1    Yoon, Y.H.2    Belfort, R.3
  • 10
    • 79953329178 scopus 로고    scopus 로고
    • FAME Study Group. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema
    • Campochiaro PA, Brown DM, Pearson A, et al; FAME Study Group. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011;118(4):626-635.e2
    • (2011) Ophthalmology , vol.118 , Issue.4 , pp. 626-6262
    • Campochiaro, P.A.1    Brown, D.M.2    Pearson, A.3
  • 11
    • 84888610885 scopus 로고    scopus 로고
    • World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects
    • World Medical Association
    • World Medical Association.World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10 .1001/jama.2013.281053
    • (2013) JAMA , vol.310 , Issue.20 , pp. 2191-2194
  • 12
    • 84938810401 scopus 로고    scopus 로고
    • A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-VEGF injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy
    • Maturi RK, Bleau L, Saunders J, Mubasher M, StewartMW. A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-VEGF injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy. Retina. 2015;35(8): 1604-1614.
    • (2015) Retina , vol.35 , Issue.8 , pp. 1604-1614
    • Maturi, R.K.1    Bleau, L.2    Saunders, J.3    Mubasher, M.4    Stewart, M.W.5
  • 13
    • 84973884837 scopus 로고    scopus 로고
    • Prospective randomized subject-masked study of intravitreal bevacizumab monotherapy versus dexamethasone implant monotherapy in the treatment of persistent diabetic macular edema
    • Shah SU, Harless A, Bleau L, Maturi RK. Prospective randomized subject-masked study of intravitreal bevacizumab monotherapy versus dexamethasone implant monotherapy in the treatment of persistent diabetic macular edema. Retina. 2016;36(10):1986-1996.
    • (2016) Retina , vol.36 , Issue.10 , pp. 1986-1996
    • Shah, S.U.1    Harless, A.2    Bleau, L.3    Maturi, R.K.4
  • 14
    • 84957927695 scopus 로고    scopus 로고
    • Ozurdex MEAD Study Group. Intraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year MEAD study
    • Maturi RK, Pollack A, Uy HS, et al; Ozurdex MEAD Study Group. Intraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year MEAD study. Retina. 2016;36(6):1143-1152.
    • (2016) Retina , vol.36 , Issue.6 , pp. 1143-1152
    • Maturi, R.K.1    Pollack, A.2    Uy, H.S.3
  • 15
    • 85014530678 scopus 로고    scopus 로고
    • Evaluating effects of switching anti-vascular endothelial growth factor drugs for age-related macular degeneration and diabetic macular edema
    • Ferris FL III, Maguire MG, Glassman AR, Ying GS, Martin DF. Evaluating effects of switching anti-vascular endothelial growth factor drugs for age-related macular degeneration and diabetic macular edema. JAMA Ophthalmol. 2017;135(2):145-149. Doi: 10.1001/jamaophthalmol.2016.4820
    • (2017) JAMA Ophthalmol , vol.135 , Issue.2 , pp. 145-149
    • Ferris, F.L.I.I.I.1    Maguire, M.G.2    Glassman, A.R.3    Ying, G.S.4    Martin, D.F.5
  • 16
    • 84962377210 scopus 로고    scopus 로고
    • Diabetic Retinopathy Clinical Research Network. Persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairment
    • Bressler SB, Ayala AR, Bressler NM, et al; Diabetic Retinopathy Clinical Research Network. Persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairment. JAMA Ophthalmol. 2016;134(3):278-285.
    • (2016) JAMA Ophthalmol , vol.134 , Issue.3 , pp. 278-285
    • Bressler, S.B.1    Ayala, A.R.2    Bressler, N.M.3
  • 17
    • 84866092409 scopus 로고    scopus 로고
    • Diabetic Retinopathy Clinical Research Network. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab
    • Bressler SB, Qin H, Beck RW, et al; Diabetic Retinopathy Clinical Research Network. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol. 2012;130(9):1153-1161.
    • (2012) Arch Ophthalmol , vol.130 , Issue.9 , pp. 1153-1161
    • Bressler, S.B.1    Qin, H.2    Beck, R.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.